1
|
Gray B, Lubbock K, Love C, Ryder E, Hudson S, Scarth J. Analytical advances in horseracing medication and doping control from 2018 to 2023. Drug Test Anal 2024. [PMID: 39010718 DOI: 10.1002/dta.3760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2024] [Revised: 06/07/2024] [Accepted: 06/20/2024] [Indexed: 07/17/2024]
Abstract
The analytical approaches taken by laboratories to implement robust and efficient regulation of horseracing medication and doping control are complex and constantly evolving. Each laboratory's approach will be dictated by differences in regulatory, economic and scientific drivers specific to their local environment. However, in general, laboratories will all be undertaking developments and improvements to their screening strategies in order to meet new and emerging threats as well as provide improved service to their customers. In this paper, the published analytical advances in horseracing medication and doping control since the 22nd International Conference of Racing Analysts and Veterinarians will be reviewed. Due to the unprecedented impact of COVID-19 on the worldwide economy, the normal 2-year period of this review was extended to over 5 years. As such, there was considerable ground to cover, resulting in an increase in the number of relevant publications included from 107 to 307. Major trends in publications will be summarised and possible future directions highlighted. This will cover developments in the detection of 'small' and 'large' molecule drugs, sample preparation procedures and the use of alternative matrices, instrumental advances/applications, drug metabolism and pharmacokinetics, the detection and prevalence of 'endogenous' compounds and biomarker and OMICs approaches. Particular emphasis will be given to research into the potential threat of gene doping, which is a significant area of new and continued research for many laboratories. Furthermore, developments in analytical instrumentation relevant to equine medication and doping control will be discussed.
Collapse
|
2
|
Angelis YS, Sakellariou P, Fragkaki AG, Karnava S, Goula O, Kiousi P, Kioukia-Fougia N, Georgakopoulos C, Loui S, Chlapana F, Kletsas D. New long-standing metabolites of 17α-methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine. Drug Test Anal 2024; 16:604-615. [PMID: 37903531 DOI: 10.1002/dta.3589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 08/17/2023] [Accepted: 10/08/2023] [Indexed: 11/01/2023]
Abstract
Novel metabolites of the anabolic androgenic steroid 17α-methyltestosterone have been detected in HepG2 cell in vitro metabolic model and in human urine. Their detection was accomplished through targeted gas chromatography-(tandem) mass spectrometry analysis that has been based on microscale synthesized standards. The related synthesis and the gas chromatography-(tandem) mass spectrometry characterization of the analytical standards are described. All newly presented metabolites have a fully reduced steroid A-ring with either an 17,17-dimethyl-18-nor-Δ13 structure or they have been further oxidized at position 16 of the steroid backbone. Metabolites with 17,17-dimethyl-18-nor-Δ13 structure may be considered as side products of phase II metabolic sulfation of the 17β-hydroxy group of methyltestosterone or its reduced tetrahydro-methyltestosterone metabolites 17α-methyl-5β-androstane-3α,17β-diol and 17α-methyl-5α-androstane-3α,17β-diol that produce the known epimeric 17β-methyl-5β-androstane-3α,17α-diol and 17β-methyl-5α-androstane-3α,17α-diol metabolites. The prospective of these new metabolites to increase detection time windows and improve identification was investigated by applying the World Anti-doping Agency TD2021IDCR criteria. The new metabolites, presented herein, complement the current knowledge on the 17α-methyltestosterone metabolism and in some cases can be used as additional long-term markers in the frame of sport doping drug testing.
Collapse
Affiliation(s)
- Yiannis S Angelis
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Panagiotis Sakellariou
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Argyro G Fragkaki
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Sophia Karnava
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
- Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - Olga Goula
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Polyxeni Kiousi
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Nassia Kioukia-Fougia
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | | | - Stella Loui
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Fotini Chlapana
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| | - Dimitris Kletsas
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
- Laboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece
| |
Collapse
|
3
|
Szabó D, Gömöry Á, Ludányi K, Vékey K, Drahos L. Very Low-Pressure CID Experiments: High Energy Transfer and Fragmentation Pattern at the Single Collision Regime. Molecules 2023; 29:211. [PMID: 38202794 PMCID: PMC10780993 DOI: 10.3390/molecules29010211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 12/20/2023] [Accepted: 12/25/2023] [Indexed: 01/12/2024] Open
Abstract
We have performed CID experiments on a triple quadrupole instrument, lowering the collision gas pressure by 50 times compared to its conventional value. The results show that at very low-collision gas pressure, single collisions dominate the spectra. Indirectly, these results suggest that under conventional conditions, 20-50 collisions may be typical in CID experiments. The results show a marked difference between low- and high-pressure CID spectra, the latter being characterized in terms of 'slow heating' and predominance of consecutive reactions. The results indicate that under single collision conditions, the collisional energy transfer efficiency is very high: nearly 100% of the center of mass kinetic energy is converted to internal energy.
Collapse
Affiliation(s)
- Dániel Szabó
- MS Proteomics Research Group, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary (Á.G.); (K.V.)
| | - Ágnes Gömöry
- MS Proteomics Research Group, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary (Á.G.); (K.V.)
| | - Krisztina Ludányi
- Department of Pharmaceutics, Semmelweis University, Hőgyes Endre 7–9, H-1092 Budapest, Hungary;
| | - Károly Vékey
- MS Proteomics Research Group, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary (Á.G.); (K.V.)
| | - László Drahos
- MS Proteomics Research Group, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary (Á.G.); (K.V.)
| |
Collapse
|
4
|
Yang X, Shi J, Li H, Zhang K, Li J, Song Q. Characterization of the metabolic fate of sinapic acid in rats. Anal Bioanal Chem 2023; 415:6511-6523. [PMID: 37695392 DOI: 10.1007/s00216-023-04929-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Revised: 08/24/2023] [Accepted: 08/28/2023] [Indexed: 09/12/2023]
Abstract
Sinapic acid (SA) is ubiquitously distributed in the plant kingdom as a free organic acid and more frequently as a biosynthetic pioneer for SA derivatives, e.g., SA esters. Broad biological and pharmacological activities have been disclosed for SA. Because of the metabolism lability property, metabolites instead of the parent compound should be the primary forms after oral treatment of SA, and those metabolites should also be rapidly observed from SA following administration of SA derivative. Hence, the metabolites might provide a primary contribution to the pharmacological properties of SA; however, the metabolite profile remains unclear. Here, our efforts were devoted to addressing this issue through deploying online energy-resolved mass spectrometry (ER-MS) to accomplish isomer identification which is the key issue hindering metabolite identification, notably those conjugated metabolites. After recording breakdown graphs of concerned fragment ions with online ER-MS, the positive correlations between optimal collision energy (OCE) and bond dissociation energy (BDE) were applied to assign candidate structures to isomeric signals. Moreover, in vitro metabolism with liver cellular subfractions, UV-triggered cis-/trans-configuration transformation, and wet-chemistry hydrogenation were carried out to justify the structures. As a result, sixteen metabolites (M1-M16) were found and confirmatively identified in rat plasma and urine following SA administration, and sulfation, glucuronidation, demethylation, reduction, and dihydroxylation served as the primary metabolic channels. Noteworthily, greater distribution occurred for sulfation and glucuronidation products while inferior distributions were observed for phase I metabolites, and the half-life (T1/2) of most metabolites was greater than that of SA. This study provides a comprehensive insight into the metabolic fate of SA. More importantly, the fortification of online ER-MS and quantum structure calculation to the conventional LC-MS program is eligible to achieve unambiguous identification of isomeric metabolites.
Collapse
Affiliation(s)
- Xiangfen Yang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Jingjing Shi
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Han Li
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Ke Zhang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Jun Li
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Qingqing Song
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
| |
Collapse
|
5
|
Albertsdóttir AD, Van Gansbeke W, Van Eenoo P, Polet M. Evaluation of alternative gas chromatographic and mass spectrometric behaviour of trimethylsilyl-derivatives of non-hydrolysed sulfated anabolic steroids. Drug Test Anal 2023; 15:1344-1355. [PMID: 36843396 DOI: 10.1002/dta.3462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 02/13/2023] [Accepted: 02/16/2023] [Indexed: 02/28/2023]
Abstract
Sulfated metabolites have shown to have potential as long-term markers (LTMs) of anabolic-androgenic steroid (AAS) abuse. The compatibility of gas chromatography-mass spectrometry (GC-MS) with trimethylsilyl (TMS)-derivatives of non-hydrolysed sulfated steroids has been demonstrated, where, after derivatisation, generally, two closely eluting isomers are formed that both have the same molecular ion [M-H2 SO4 ]•+ . Sulfated reference standards are in limited commercial availability, and therefore, the current knowledge of the GC-MS behaviour of these compounds is mainly based on sulfating and analysing the available standard reference material. This procedure can unfortunately not cover all of the current known LTMs as these are often not available as pure substance. Therefore, in theory, some metabolites could be missed as they exhibit alternative behaviour. To investigate the matter, in-house sulfated reference materials that bear resemblance to known sulfated LTMs were analysed on GC-MS in their TMS-derivatised non-hydrolysed state. The (alternative) gas chromatographic and mass spectrometric behaviour was mapped, evaluated and linked to the corresponding steroid structures. Afterwards, using fraction collection, known sulfated LTMs were isolated from excretion urine to confirm the observed findings. The categories that were selected were mono-hydroxy-diones, 17-methyl-3,17-diols and 17-keto-3,16-diols as these are commonly encountered AAS conformations. The ability to predict the GC-MS behaviour of non-hydrolysed sulfated AAS metabolites is the corner stone of finding new metabolites. This knowledge is also essential, for example, for understanding AAS detection analyses, for the mass spectrometric characterization of metabolites of new designer steroids or when one needs to characterize an unknown steroid structure.
Collapse
Affiliation(s)
| | - Wim Van Gansbeke
- Doping Control Laboratory (DoCoLab), Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
| | - Peter Van Eenoo
- Doping Control Laboratory (DoCoLab), Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
| | - Michael Polet
- Doping Control Laboratory (DoCoLab), Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
| |
Collapse
|